Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Steroid compound for use in the treatment of hepatic encephalopathy

Steroid compound for use in the treatment of hepatic encephalopathy

US Patent 10342804 · Granted Jul 9, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with2022
Pharmaceutical formulation of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one oxi2021
3-beta-hydroxy-5-alpha-pregnan-20-one for use in treatment of essential tremor2021
3-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatment2021
Pharmaceutical formulation of 3α-ethynyl-3β-hydroxyandrostan-17-one oxime2020
3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treat2019
Methods for treating hypersomnolence2019
Methods for treating hypersomnolence2019
Steroid compound for use in the treatment of hepatic encephalopathy2017
Steroid compound for use in the treatment of hepatic encephalopathy2017
Steroid compound for use in the treatment of hepatic encephalopathy2017
Steroid compound for use in the treatment of hepatic encephalopathy2017